116 related articles for article (PubMed ID: 20706284)
1. Combination intravitreal rituximab and methotrexate for massive subretinal lymphoma.
Yeh S; Wilson DJ
Eye (Lond); 2010 Oct; 24(10):1625-7. PubMed ID: 20706284
[No Abstract] [Full Text] [Related]
2. Intraocular (vitreoretinal) lymphoma following primary testicular lymphoma.
Grange LK; Jacobs-El N; Wiley HE; Kurup S; Chan CC; Sen HN
Can J Ophthalmol; 2013 Aug; 48(4):e95-7. PubMed ID: 23931497
[No Abstract] [Full Text] [Related]
3. The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma.
Mitrovic Z; Bast M; Bierman PJ; Bociek RG; Vose JM; Chan WC; Armitage JO
Br J Haematol; 2012 May; 157(3):401-3. PubMed ID: 22224728
[No Abstract] [Full Text] [Related]
4. Use of intravitreal rituximab for treatment of vitreoretinal lymphoma.
Larkin KL; Saboo US; Comer GM; Forooghian F; Mackensen F; Merrill P; Sen HN; Singh A; Essex RW; Lake S; Lim LL; Vasconcelos-Santos DV; Foster CS; Wilson DJ; Smith JR
Br J Ophthalmol; 2014 Jan; 98(1):99-103. PubMed ID: 24158837
[TBL] [Abstract][Full Text] [Related]
5. Relevance of the International Prognostic Index in the rituximab era.
Tay K; Tai D; Tao M; Quek R; Ha TC; Lim ST
J Clin Oncol; 2011 Jan; 29(1):e14; author reply e15. PubMed ID: 21115864
[No Abstract] [Full Text] [Related]
6. Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.
Ruan J; Martin P; Furman RR; Lee SM; Cheung K; Vose JM; Lacasce A; Morrison J; Elstrom R; Ely S; Chadburn A; Cesarman E; Coleman M; Leonard JP
J Clin Oncol; 2011 Feb; 29(6):690-7. PubMed ID: 21189393
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic criteria for primary ocular lymphoma.
Arcinue CA; Hochberg F; Neumann R; Foster CS
Ophthalmology; 2013 Mar; 120(3):646-646.e2. PubMed ID: 23714608
[No Abstract] [Full Text] [Related]
8. Secondary Vitreoretinal Lymphoma Masquerading as Acute Retinal Necrosis.
Ryan ME; Shantha JG; Grossniklaus HE; Yeh S
Ophthalmic Surg Lasers Imaging Retina; 2015; 46(10):1048-50. PubMed ID: 26599249
[TBL] [Abstract][Full Text] [Related]
9. [Treatment strategy for central nervous system involvement in intravascular large B-cell lymphoma].
Shimada K
Brain Nerve; 2011 May; 63(5):467-72. PubMed ID: 21515926
[TBL] [Abstract][Full Text] [Related]
10. Testicular lymphoma, intraocular (vitreoretinal) lymphoma, and brain lymphoma: involvement of three immunoprivileged sites in one patient.
Pe'er J; Rowe JM; Frenkel S; Dann EJ
Am J Hematol; 2010 Aug; 85(8):631-3. PubMed ID: 20658596
[No Abstract] [Full Text] [Related]
11. Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma.
Furman RR; Martin P; Ruan J; Cheung YK; Vose JM; LaCasce AS; Elstrom R; Coleman M; Leonard JP
Cancer; 2010 Dec; 116(23):5432-9. PubMed ID: 20665890
[TBL] [Abstract][Full Text] [Related]
12. Diffuse large B-cell lymphoma with germinal center B-cell phenotype mimicking primary effusion lymphoma.
Lim Y; Kim TY; Choi IS; Kim BS; Lee TS; Kim JE; Chang MS; Kim KH
J Clin Oncol; 2011 Apr; 29(10):e271-3. PubMed ID: 21220599
[No Abstract] [Full Text] [Related]
13. Front-line management of diffuse large B cell lymphoma.
Cabanillas F
Curr Opin Oncol; 2010 Nov; 22(6):642-5. PubMed ID: 20811278
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic impact of bone marrow involvement (BMI) and therapies in diffuse large B cell lymphoma].
Yi SH; Xu Y; Zou DH; An G; Zhao YZ; Qi JY; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):307-12. PubMed ID: 19799125
[TBL] [Abstract][Full Text] [Related]
15. Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%.
Mohamedbhai SG; Sibson K; Marafioti T; Kayani I; Lowry L; Goldstone AH; Linch DC; Ardeshna KM
Br J Haematol; 2011 Jan; 152(2):175-81. PubMed ID: 21092025
[TBL] [Abstract][Full Text] [Related]
16. Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey.
Tarella C; Zanni M; Magni M; Benedetti F; Patti C; Barbui T; Pileri A; Boccadoro M; Ciceri F; Gallamini A; Cortelazzo S; Majolino I; Mirto S; Corradini P; Passera R; Pizzolo G; Gianni AM; Rambaldi A
J Clin Oncol; 2008 Jul; 26(19):3166-75. PubMed ID: 18490650
[TBL] [Abstract][Full Text] [Related]
17. Can rituximab change the usually dismal prognosis of patients with intravascular large B-cell lymphoma?
Ferreri AJ; Dognini GP; Govi S; Crocchiolo R; Bouzani M; Bollinger CR; D'Incan M; Delaporte E; Hamadani M; Jardin F; Martusewicz-Boros M; Montanari M; Szomor A; Zucca E; Cavalli F; Ponzoni M
J Clin Oncol; 2008 Nov; 26(31):5134-6; author reply 5136-7. PubMed ID: 18838697
[No Abstract] [Full Text] [Related]
18. Methotrexate-induced periorbital radiation recall.
Kiel PJ; Jones KL
Ann Pharmacother; 2011 Jan; 45(1):133. PubMed ID: 21205951
[No Abstract] [Full Text] [Related]
19. Stem cell transplantation for diffuse large B-cell lymphoma patients in the rituximab era.
Mounier N; Gisselbrecht C
Curr Opin Oncol; 2011 Mar; 23(2):209-13. PubMed ID: 21169834
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of primary mediastinal large B-cell lymphomas].
Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
